{"summary":"Scientific leader with strong track record in oncology and translational science (>15 publications in high ranked journals), leading cross-functional teams at AstraZeneca Computational Pathology. Academic experience (Notch signaling and pancreatic cancer), experience with computational pathology, IHC\/mIF assay and histopathology workflow design, drug development and clinical trial landscape, biomarker development and companion diagnostics.","lastName":"Hidalgo Sastre","objectUrn":"urn:li:member:36296779","geoRegion":"Greater Munich Metropolitan Area","fullName":"Ana Hidalgo Sastre","firstName":"Ana","currentPositions":[{"companyName":"AstraZeneca","description":"Lead Computational Pathology x-functional teams to identify predictive image analysis-based tissue biomarkers. Define and implement strategy for novel biomarker identification for late stage ADC programs. Translational Science team manager.","title":"Director, Translational Science - Computational Pathology","companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"geographicArea":"Cambridgeshire","country":"United Kingdom","city":"Cambridge","postalCode":"CB2 0AA","line2":"Cambridge Biomedical Campus","line1":"1 Francis Crick Avenue"},"website":"http:\/\/www.astrazeneca.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/astrazeneca\/","industry":"Pharmaceutical Manufacturing"},"companyUrn":"urn:li:fs_salesCompany:1603","tenureAtCompany":{"numYears":4,"numMonths":6},"startedOn":{"month":11,"year":2021}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)","projects":[],"contactInfo":{},"industry":"Pharmaceutical Manufacturing","educations":[{"endedOn":{"year":2012},"degree":"PhD","eduId":54363672,"schoolUrn":"urn:li:fs_salesSchool:166652","school":"urn:li:fs_salesSchool:166652","fieldsOfStudy":["Developmental biology"],"schoolName":"The University of Manchester","startedOn":{"year":2008}},{"endedOn":{"year":2008},"degree":"MRes","eduId":27503384,"schoolUrn":"urn:li:fs_salesSchool:7244","school":"urn:li:fs_salesSchool:7244","fieldsOfStudy":["Advanced Genetic Analysis"],"startedOn":{"year":2007}},{"endedOn":{"year":2007},"degree":"Licenciada","eduId":27503545,"schoolUrn":"urn:li:fs_salesSchool:47842","school":"urn:li:fs_salesSchool:47842","fieldsOfStudy":["Molecular biology"],"startedOn":{"year":2002}}],"skills":[{"numOfEndorsement":3,"name":"Critical Thinking"},{"numOfEndorsement":3,"name":"Self-esteem"},{"numOfEndorsement":5,"name":"Molecular Biology"},{"numOfEndorsement":6,"name":"Developmental Biology"},{"numOfEndorsement":2,"name":"signalling pathways"},{"numOfEndorsement":2,"name":"Biochemistry"},{"numOfEndorsement":9,"name":"Molecular Genetics"},{"numOfEndorsement":8,"name":"Cell Culture"},{"numOfEndorsement":8,"name":"Agarose Gel Electrophoresis"},{"numOfEndorsement":2,"name":"Immunoprecipitation"},{"numOfEndorsement":2,"name":"DNA Sequencing"},{"numOfEndorsement":2,"name":"Western Blotting"},{"numOfEndorsement":2,"name":"Pancreatic cancer"}],"numOfConnections":677,"patents":[],"headline":"Director, Translational Science at AstraZeneca","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/anahidalgosastre","organizations":[],"location":"Greater Munich Metropolitan Area","publications":[{"name":"Rapid cleavage of RNA by RNase E in the absence of 5' monophosphate stimulation.","publishedOn":{"month":5,"year":2010},"publisher":"Mol Microbiol","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19889093","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"}]},{"name":"Dishevelled limits Notch signalling through inhibition of CSL.","publishedOn":{"month":12,"day":1,"year":2012},"publisher":"Development","url":"http:\/\/dev.biologists.org\/content\/139\/23\/4405.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAWAq6sBOQiucfxUlKk4I3wNo7ZZAPpn2zU,NAME_SEARCH,glaG)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAASixd8BOGYEOchk_0YldJN5DwsIn4MALMc,NAME_SEARCH,Rrep)"}]},{"name":"Wnt-Notch signalling crosstalk in development and disease.","publishedOn":{"month":9,"year":2014},"publisher":"Cell Mol Life Sci.","url":"http:\/\/link.springer.com\/article\/10.1007%2Fs00018-014-1644-x","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAA7yv18Bsvla20OVuArab1eTSos1zBPpvRo,NAME_SEARCH,lcsj)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"}]},{"name":"Membranous CD24 drives the epithelial phenotype of pancreatic Cancer.","publishedOn":{"month":5,"year":2016},"publisher":"Oncotarget","url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=view&path[]=9402&pubmed-linkout=1","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"}]},{"name":"Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.","publishedOn":{"month":9,"day":14,"year":2016},"publisher":"Am J Pathol.","url":"http:\/\/ajp.amjpathol.org\/article\/S0002-9440(16)30310-8\/pdf","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"}]},{"name":"Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions.","publishedOn":{"month":12,"day":24,"year":2016},"publisher":"EBioMedicine","url":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5233824\/","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAxFCZgB-YpwETzL7kKM-3Kg0SQtBDGujak,NAME_SEARCH,YyYT)"}]},{"name":"Atypical flat lesions derive from pancreatic acinar cells.","publishedOn":{"month":5,"year":2017},"publisher":"Pancreatology","url":"http:\/\/www.pancreatology.net\/article\/S1424-3903(17)30080-7\/fulltext","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAIp2EsBNjRkaDfmRm7TuwbV8jqQY8C8x6s,NAME_SEARCH,dsxV)"}]}],"positions":null,"posts":[{"createdAt":1716913380000,"insightId":"b13322cd-81fa-4990-acf6-b80a01623abd","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":19},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7201256670881034240","threadUrn":"urn:li:ugcPost:7201256670881034240","reactionsCount":20,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7201256670881034240","message":{"attributes":[{"start":674,"length":23,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:computationalpathology"}}},{"start":698,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:scienceneverstops"}}}],"text":"It was energizing to attend the 107th annual conference of the German Society for Pathology (DGP) with the motto \"\u201eNext Generation Pathology \u201c last week in Munich. I met many colleagues from the field and made new connections. \n\nMy take away from the conference:\n- Computational pathology was everywhere, HE-based algorithms and TILs were the most spoken about\n- ADCs are at the forefront of targeted therapy, their complex MoA may require novel, complex diagnostics\n- The way is long until we see full adoption of digital pathology in the clinics and reimbursement but we are paving the way\n- Mass Spectrometry and spatial biology are strong players in the research field\n\n#computationalpathology #scienceneverstops"},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000189452401"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7201255470609711104","message":{"attributes":[{"start":501,"length":18,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:36296779"}}},{"start":521,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:100777150"}}},{"start":537,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:399959816"}}},{"start":556,"length":20,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:214789675"}}},{"start":578,"length":24,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:43921832"}}},{"start":603,"length":23,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:computationalpathology"}}},{"start":627,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:dgp"}}},{"start":632,"length":3,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:ai"}}},{"start":636,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:pathology"}}},{"start":647,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:scienceneverstopps"}}}],"text":"The past days I\u2019ve been attending the annual conference of the German Society for Pathology (DGP) in Munich. The motto this year was \u201eNext Generation Pathology\u201c, focusing on molecular pathology, personalized medicine, computational pathology, and comparative pathology.\u00a0We had the opportunity to discuss the rapidly evolving field of computational pathology with many great researchers \u2013 it\u2019s great to see that more and more pathologists are keen on being part of this next generation of pathology! \n\nAna Hidalgo Sastre, G\u00fcnter Schmidt, Harald Dr. Hessel, Christian Eisen, PhD. Dr. Dennie Andresen, MBA\n#computationalpathology #DGP #AI #pathology #scienceneverstopps"},"entityUrn":"urn:li:ugcPost:7201255470609711104"},"entityUrn":"urn:li:ugcPost:7201256670881034240"}}},{"createdAt":1710022380000,"insightId":"f2517b38-a3d9-4a7f-8a11-cbc6fa7d4a04","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQEYP1pz75rzlw\/articleshare-shrink_800\/0\/1711380430638?e=1717977600&v=beta&t=-WWF6KzTCg_KPcQOCnVm2x8mUH9V0_G1tOqiWKmGt_8","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4E27AQEYP1pz75rzlw\/articleshare-shrink_800\/0\/1711380430638?e=1717977600&v=beta&t=-WWF6KzTCg_KPcQOCnVm2x8mUH9V0_G1tOqiWKmGt_8"}]},"description":"Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer...","resolvedUrl":"https:\/\/pharmaphorum.com\/oncology\/12-questions-jorge-reis-filho","title":"12 Questions with Jorge Reis-Filho"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":17},{"type":"EMPATHY","count":6},{"type":"APPRECIATION","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7172353812181966848","threadUrn":"urn:li:activity:7172353812181966848","reactionsCount":26,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7172353811582181376","message":{"attributes":[{"start":242,"length":18,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:scienceneverstops"}}},{"start":261,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:495700912"}}},{"start":275,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:100777150"}}},{"start":290,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:19089665"}}},{"start":305,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1066149917"}}}],"text":"What is it that gets you out of bed? For me is being part of that team who has the potential to change the paradigm of cancer treatment. Proud of working at AZ in Computational Pathology at the intersection of pharma, science and technology. #scienceneverstops Hadassah Sade G\u00fcnter Schmidt Mark Gustavson Jorge Reis-Filho"},"entityUrn":"urn:li:share:7172353811582181376"}}},{"createdAt":1713357000000,"insightId":"ae35f599-bd7f-4b3b-ba4d-a7132e42801e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7186095804896460800,7186340256449740801)","threadUrn":"urn:li:ugcPost:7186095804896460800","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congrats Andy!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7186095804896460800"}}},{"createdAt":1711783320000,"insightId":"6e392045-c4de-48e4-a4a4-77614473c53e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7178772521066930179,7179739826781364224)","threadUrn":"urn:li:ugcPost:7178772521066930179","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congrats Pierre! I\u2019m so happy for you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7178772521066930179"}}}]}